Cipla Launches Authorized Generic of Aloxi
Cipla USA, Inc. has announced the launch of an authorized generic version of Aloxi in the US under applicable agreements with Helsinn Healthcare SA, in response to the at-risk launch by Teva.
Aloxi – palonosetron hydrochloride injections (0.25 mg base/5 ml) – is indicated for prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy and for prevention of acute nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy.
Helsinn Healthcare SA currently manufactures and markets Aloxi in the US through its licensee Eisai Inc. and its affiliate Helsinn Therapeutics (US) Inc. According to IMS Health, the brand had U.S. sales of approximately $460-mn for the 12-month period ending November 2017.
2026-10-08
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Braskem Weighs Out-of-Court Restructuring as $10 Billion Debt Burden Deepens Petrochemical Crisis
-
Ancora Offers Up to $1.2 Billion for H.B. Fuller Building Adhesives Business
-
BASF Raises Acid Chloride and Chloroformate Capacity by 30% at Ludwigshafen
-
BASF Sues Apple Over Face Authentication Patents Used in Dozens of iPhones and iPads
-
Sinopec Oilfield Service Chairman Steps Down, Sinopec Shanghai Sales Branch Deputy GM Investigated on Consecutive Days
-
Ineos Rescues UK's Last Dichloroethane Plant
-
BASF Raises European Amines by Up to 30% and LANXESS Raises Inorganic Pigments by Up to 20%
-
Covestro Minority Shareholder Squeeze-Out Price Set at €59.46 per Share
-
BASF Technology with CFRP Lands in Nanjing: High-Performance Dispersant Production Line Officially Commissioned
-
BASF’s €8.7 Billion Zhanjiang Verbund Site Fully Operational
Recommend Reading
-
Syensqo Launches AI-Developed Coffee Peptide for Scalp Care
-
Lipoid Kosmetik Announces New U.S. Market Distribution Partnership with Omya
-
“Shutdown Equals Price Hike”: TDI Market Enters a New Era of “Scarcity Games”
-
An Explosion Has Occurred in the Jubail Industrial City, Putting 6–8% of Global Petrochemical Production Capacity at Risk
-
AkzoNobel Rejects €12.5 Billion Offer from Nippon Paint and Sherwin-Williams, Sticks to Merger with Axalta
-
Business Society’s MTBE Market Outlook on August 13, 2026: Fluctuating Trend
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 11, 2026: Consolidation
-
Premium Global Chemical Sourcing Requests (24-28 Nov 2025)
-
Business Society’s Market Outlook for Petroleum Coke on August 11, 2026: Volatile
-
Business Society’s View on Gasoline Market Trends on August 13, 2026: Volatile but Rising